STERIS plc (NYSE:STE) Expected to Post Earnings of $1.80 Per Share


Share on StockTwits

Equities analysts expect that STERIS plc (NYSE:STE) will report earnings of $1.80 per share for the current quarter, according to Zacks. Three analysts have issued estimates for STERIS’s earnings. The lowest EPS estimate is $1.78 and the highest is $1.81. STERIS posted earnings per share of $1.64 during the same quarter last year, which would indicate a positive year over year growth rate of 9.8%. The firm is scheduled to announce its next quarterly earnings report after the market closes on Tuesday, May 18th.

On average, analysts expect that STERIS will report full-year earnings of $6.31 per share for the current financial year, with EPS estimates ranging from $6.28 to $6.33. For the next financial year, analysts expect that the company will report earnings of $6.97 per share, with EPS estimates ranging from $6.91 to $7.00. Zacks Investment Research’s EPS averages are a mean average based on a survey of analysts that that provide coverage for STERIS.

STERIS (NYSE:STE) last announced its quarterly earnings data on Tuesday, February 2nd. The medical equipment provider reported $1.73 EPS for the quarter, beating the consensus estimate of $1.52 by $0.21. The business had revenue of $808.90 million during the quarter, compared to analysts’ expectations of $794.08 million. STERIS had a net margin of 13.97% and a return on equity of 14.44%. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.45 EPS.

Several equities analysts recently issued reports on the stock. Robert W. Baird boosted their target price on shares of STERIS from $200.00 to $230.00 and gave the company an “outperform” rating in a research note on Wednesday, January 13th. Raymond James reiterated a “hold” rating on shares of STERIS in a research report on Wednesday, January 20th. Zacks Investment Research lowered shares of STERIS from a “buy” rating to a “hold” rating and set a $227.00 target price on the stock. in a research note on Tuesday, April 27th. Finally, KeyCorp lifted their price target on STERIS from $224.00 to $227.00 and gave the company an “overweight” rating in a research note on Wednesday, March 17th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $216.80.

In related news, VP Julia Madsen sold 1,000 shares of the stock in a transaction on Tuesday, April 20th. The stock was sold at an average price of $210.00, for a total value of $210,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.20% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Toews Corp ADV acquired a new position in shares of STERIS during the 1st quarter worth approximately $933,000. Envestnet Asset Management Inc. grew its holdings in STERIS by 4.2% in the 1st quarter. Envestnet Asset Management Inc. now owns 437,378 shares of the medical equipment provider’s stock valued at $83,312,000 after buying an additional 17,744 shares in the last quarter. Oak Ridge Investments LLC grew its holdings in STERIS by 973.8% in the 1st quarter. Oak Ridge Investments LLC now owns 66,405 shares of the medical equipment provider’s stock valued at $12,649,000 after buying an additional 60,221 shares in the last quarter. Commonwealth Equity Services LLC raised its holdings in shares of STERIS by 6.4% during the 1st quarter. Commonwealth Equity Services LLC now owns 4,301 shares of the medical equipment provider’s stock worth $819,000 after acquiring an additional 260 shares during the period. Finally, Victory Capital Management Inc. boosted its position in shares of STERIS by 1,512.7% during the 1st quarter. Victory Capital Management Inc. now owns 23,433 shares of the medical equipment provider’s stock valued at $4,463,000 after acquiring an additional 21,980 shares during the last quarter. 90.01% of the stock is currently owned by institutional investors and hedge funds.

STERIS stock traded down $1.49 during mid-day trading on Tuesday, hitting $211.98. The company had a trading volume of 602,434 shares, compared to its average volume of 635,855. The company has a market capitalization of $18.09 billion, a price-to-earnings ratio of 42.99 and a beta of 0.59. STERIS has a 12-month low of $139.51 and a 12-month high of $216.74. The company’s fifty day moving average is $199.31 and its 200-day moving average is $189.52. The company has a current ratio of 2.64, a quick ratio of 2.00 and a debt-to-equity ratio of 0.28.

About STERIS

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: How To Calculate Debt-to-Equity Ratio

Get a free copy of the Zacks research report on STERIS (STE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.